<?xml version="1.0" encoding="utf-8"?>
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended" xmlns:xlink="http://www.w3.org/1999/xlink">
    <loc xlink:type="locator" xlink:href="959800FXZQY7U3P1G969-2024-12-31.xsd#faesfarmasa_ActivosIntangibles" xlink:label="faesfarmasa_ActivosIntangibles" />
    <loc xlink:type="locator" xlink:href="959800FXZQY7U3P1G969-2024-12-31.xsd#faesfarmasa_DividendoACuenta" xlink:label="faesfarmasa_DividendoACuenta" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" />
    <loc xlink:type="locator" xlink:href="959800FXZQY7U3P1G969-2024-12-31.xsd#faesfarmasa_BeneficioDelEjercicio" xlink:label="faesfarmasa_BeneficioDelEjercicio" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
    <labelArc xlink:type="arc" xlink:from="faesfarmasa_ActivosIntangibles" xlink:to="label_faesfarmasa_faesfarmasaActivosIntangibles_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="faesfarmasa_DividendoACuenta" xlink:to="label_faesfarmasa_faesfarmasaDividendoACuenta_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="label_faesfarmasa_ifrs-fullNoncurrentAssets_PeriodStart" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="label_faesfarmasa_ifrs-fullGainsLossesOnExchangeDifferencesOnTranslationNetOfTax_Total" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <labelArc xlink:type="arc" xlink:from="faesfarmasa_BeneficioDelEjercicio" xlink:to="label_faesfarmasa_faesfarmasaBeneficioDelEjercicio_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="label_faesfarmasa_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_Total" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <label xlink:label="label_faesfarmasa_faesfarmasaActivosIntangibles_Standard" id="faesfarmasa_faesfarmasaActivosIntangibles_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Activos intangibles</label>
    <label xlink:label="label_faesfarmasa_faesfarmasaDividendoACuenta_Standard" id="faesfarmasa_faesfarmasaDividendoACuenta_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Dividendo a cuenta</label>
    <label xlink:label="label_faesfarmasa_ifrs-fullNoncurrentAssets_PeriodStart" id="faesfarmasa_ifrs-fullNoncurrentAssets_PeriodStart" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="es">Activos no corrientes (abstract)</label>
    <label xlink:label="label_faesfarmasa_ifrs-fullGainsLossesOnExchangeDifferencesOnTranslationNetOfTax_Total" id="faesfarmasa_ifrs-fullGainsLossesOnExchangeDifferencesOnTranslationNetOfTax_Total" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="es">Ganancias (pérdidas) por diferencias de cambio en la conversión, netas de impuestos	</label>
    <label xlink:label="label_faesfarmasa_faesfarmasaBeneficioDelEjercicio_Standard" id="faesfarmasa_faesfarmasaBeneficioDelEjercicio_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Beneficio del ejercicio</label>
    <label xlink:label="label_faesfarmasa_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_Total" id="faesfarmasa_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_Total" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="es">Aumento o disminucion neta de efectivo y otros medios liquidos equivalentes</label>
  </labelLink>
</linkbase>